These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8022865)

  • 1. Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases.
    Perie J; Riviere-Alric I; Blonski C; Gefflaut T; Lauth de Viguerie N; Trinquier M; Willson M; Opperdoes FR; Callens M
    Pharmacol Ther; 1993 Nov; 60(2):347-65. PubMed ID: 8022865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
    Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational concepts and the study of active molecules against various trypanosomiases].
    Périé J; de Albuquerque C; Blonski C; Chauvière G; Gefflaut T; Page P; Trinquier M; Willson M
    Bull Soc Pathol Exot; 1994; 87(5):353-61. PubMed ID: 7496200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.
    Cáceres AJ; Michels PA; Hannaert V
    Mol Biochem Parasitol; 2010 Jan; 169(1):50-4. PubMed ID: 19748525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified berberine and protoberberines from Enantia chlorantha as potential inhibitors of Trypanosoma brucei.
    Nyasse B; Nkwengoua E; Sondengam B; Denier C; Willson M
    Pharmazie; 2002 Jun; 57(6):358-61. PubMed ID: 12116870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of Trypanosoma brucei GAPDH by 1,3-bisphospho-D-glyceric acid (1,3-diPG) analogues.
    Ladame S; Bardet M; Périé J; Willson M
    Bioorg Med Chem; 2001 Mar; 9(3):773-83. PubMed ID: 11310612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei.
    Dax C; Duffieux F; Chabot N; Coincon M; Sygusch J; Michels PA; Blonski C
    J Med Chem; 2006 Mar; 49(5):1499-502. PubMed ID: 16509566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
    Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
    Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei.
    Willson M; Callens M; Kuntz DA; Perié J; Opperdoes FR
    Mol Biochem Parasitol; 1993 Jun; 59(2):201-10. PubMed ID: 8341319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase.
    Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ
    Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolysis as a target for the design of new anti-trypanosome drugs.
    Verlinde CL; Hannaert V; Blonski C; Willson M; Périé JJ; Fothergill-Gilmore LA; Opperdoes FR; Gelb MH; Hol WG; Michels PA
    Drug Resist Updat; 2001 Feb; 4(1):50-65. PubMed ID: 11512153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: Drug Discovery for Neglected Diseases.
    Andricopulo AD; Ferreira LLG
    Curr Top Med Chem; 2018; 18(5):313-314. PubMed ID: 29968533
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): their effects on three selected glycolytic enzymes of Trypanosoma brucei.
    Ngantchou I; Nyasse B; Denier C; Blonski C; Hannaert V; Schneider B
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3495-8. PubMed ID: 20529682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
    Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
    Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
    J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae.
    Callens M; Hannaert V
    Ann Trop Med Parasitol; 1995 Dec; 89 Suppl 1():23-30. PubMed ID: 8745924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis.
    Nowicki MW; Tulloch LB; Worralll L; McNae IW; Hannaert V; Michels PA; Fothergill-Gilmore LA; Walkinshaw MD; Turner NJ
    Bioorg Med Chem; 2008 May; 16(9):5050-61. PubMed ID: 18387804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei.
    Pasti C; Rinaldi E; Cervellati C; Dallocchio F; Hardré R; Salmon L; Hanau S
    Bioorg Med Chem; 2003 Apr; 11(7):1207-14. PubMed ID: 12628648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.